Search results for “TOR signaling” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 100 patents, we discovered top 43 key players by total patent application. Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Cell Therapy Ltd. are dominant in this area. They take 22.00% of the total patent filing.
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 12
Bristol Myers Squibb Co.
New York, United States
Patent: 5
Cell Therapy Ltd.
CARDIFF, United Kingdom
Patent: 5
Chiron Corp.
California, United States
Patent: 4
Research Development Foundation
United States
Patent: 4
Novartis AG
Basel-Stadt, Switzerland
Patent: 3
Takeda Pharmaceutical Co., Ltd.
Osaka-fu, Japan
Patent: 3
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 3
PharmAbcine Inc.
South Korea
Patent: 3
Takara Bio Europe AB
Sweden
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 3 patents, we discovered top 3 start-ups by total patent application.
STARTUP
CoImmune, Inc.
North Carolina, United States
Patent: 1
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 1
STARTUP
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 1
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 5 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Noile-Immune Biotech, Inc., Université de Montpellier I, Institut National de la Santé et de la Recherche Médicale take 60.00% of patent filing during this period.
STARTUP
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 1
Université de Montpellier I
France
Patent: 1
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 1
Boditech Med, Inc.
South Korea
Patent: 1
Ajou University Industry-Academic Cooperation Foundation
South Korea
Patent: 1
Kaifu (Suzhou) Biomedicine Co., Ltd.
Jiangsu Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 5 patents in last 5 years, we discover 6 new entrants. Noile-Immune Biotech, Inc., Université de Montpellier I, Institut National de la Santé et de la Recherche Médicale are the most active new entrants in this area.
STARTUP
Noile-Immune Biotech, Inc.
Tokyo-to, Japan
Patent: 1
Université de Montpellier I
France
Patent: 1
STARTUP
Institut National de la Santé et de la Recherche Médicale
France
Patent: 1
Boditech Med, Inc.
South Korea
Patent: 1
Ajou University Industry-Academic Cooperation Foundation
South Korea
Patent: 1
Kaifu (Suzhou) Biomedicine Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 26 patents, we discovered top 11 universities and scientific research institutions by total patent application. Dartmouth College, Massachusetts Institute of Technology, Peking University are dominant in this area. They take 23.08% of the total patent filing.
Dartmouth College
New Hampshire, United States
Patent: 2
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 1
Peking University
Beijing Shi, China
Patent: 1
Kobe University
Kyoto-fu, Japan
Patent: 1
Vrije Universiteit Brussel
Brussels Hoofdstedelijk Gewest, Belgium
Patent: 1
Fudan University
Shanghai Shi, China
Patent: 1
Yonsei University
South Korea
Patent: 1
University of Strasbourg
France
Patent: 1
Osaka University
Osaka-fu, Japan
Patent: 1
University of Innsbruck
Tirol, Austria
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: